1. Home
  2. FTK vs GOSS Comparison

FTK vs GOSS Comparison

Compare FTK & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flotek Industries Inc.

FTK

Flotek Industries Inc.

HOLD

Current Price

$16.57

Market Cap

522.1M

Sector

Industrials

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$2.14

Market Cap

615.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTK
GOSS
Founded
1985
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
522.1M
615.7M
IPO Year
1997
2018

Fundamental Metrics

Financial Performance
Metric
FTK
GOSS
Price
$16.57
$2.14
Analyst Decision
Buy
Strong Buy
Analyst Count
1
7
Target Price
$20.00
$8.83
AVG Volume (30 Days)
232.9K
5.3M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
440.00
78.81
EPS
0.78
N/A
Revenue
$136,092,000.00
$114,701,000.00
Revenue This Year
$20.30
N/A
Revenue Next Year
$11.14
$6.41
P/E Ratio
$22.29
N/A
Revenue Growth
214.53
N/A
52 Week Low
$6.05
$0.76
52 Week High
$20.09
$3.87

Technical Indicators

Market Signals
Indicator
FTK
GOSS
Relative Strength Index (RSI) 49.32 34.41
Support Level $16.88 $2.24
Resistance Level $17.98 $2.50
Average True Range (ATR) 1.04 0.20
MACD -0.03 -0.01
Stochastic Oscillator 49.71 3.80

Price Performance

Historical Comparison
FTK
GOSS

About FTK Flotek Industries Inc.

Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: